Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Stanford University
With
National Institutes of Health (NIH)
National Institute for Biomedical Imaging and Bioengineering (NIBIB)
The objective of this study is to assess the diagnostic accuracy of a new non-contrast MRI method for breast cancer detection. The study design is a single arm observational study. The new technique will be added on to the standard sequences that a women undergoes during a breast MRI. The resulting images will be compared with her standard breast MRI images, and with results of subsequent pathology.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
2\. Female
You may not be if
2\. Pregnancy
3\. Patient undergoing chemotherapy. These patients are excluded because chemotherapy changes the biology of breast cancers. Since the ultimate objective of the research is to develop a new imaging method for breast MRI screening (detection of previously unknown tumors), results in treated tumors would not be relevant. Including treated tumors could yield a misleading assessment of the performance of the new method since treated tumors have different imaging characteristics than de novo tumors.
Clareo Health | High Resolution 3D Diffusion-weighted Breast MRI
